(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,18-trihydroxy-12-oxo-12-sulfanyl-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one

C84H100N36O48P8S4 — CID 162264085

About (1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,18-trihydroxy-12-oxo-12-sulfanyl-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one

(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,18-trihydroxy-12-oxo-12-sulfanyl-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one (PubChem CID 162264085) has the molecular formula C84H100N36O48P8S4 and a molecular weight of 2757.99 g/mol. Its IUPAC name is (1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,18-trihydroxy-12-oxo-12-sulfanyl-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one.

Molecular Properties

• Compound Name: (1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,18-trihydroxy-12-oxo-12-sulfanyl-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one
• PubChem CID: 162264085
• Molecular Formula: C84H100N36O48P8S4
• Molecular Weight: 2757.99 g/mol
• Exact Mass: 2756.33
• IUPAC Name: (1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,18-trihydroxy-12-oxo-12-sulfanyl-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one
• SMILES: Cc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)(O)O[C@@H]4C(O)[C@H](n5cnc6c(=O)[nH]c(N)nc65)O[C@@H]4COP(=O)(O)O[C@@H]3C2O)c(=O)[nH]1.Cc1nc2c(ncn2[C@@H]2O[C@@H]3COP(O)(=S)O[C@@H]4C(O)[C@H](n5cnc6c(=O)[nH]c(N)nc65)O[C@@H]4COP(=O)(S)O[C@@H]3C2O)c(=O)[nH]1.Nc1ccnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@@H]3C(O)[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)O[C@@H]2C1O.Nc1ccnc2c1ncn2[C@@H]1O[C@@H]2COP(O)(=S)O[C@@H]3C(O)[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(O)(=S)O[C@@H]2C1O
• InChI: InChI=1S/C21H25N9O14P2.C21H25N9O12P2S2.C21H25N9O12P2.C21H25N9O10P2S2/c1-6-25-15-9(17(33)26-6)23-4-29(15)19-11(31)13-7(41-19)2-39-46(37,38)44-14-8(3-40-45(35,36)43-13)42-20(12(14)32)30-5-24-10-16(30)27-21(22)28-18(10)34;1-6-25-15-9(17(33)26-6)23-4-29(15)19-11(31)13-7(39-19)2-37-44(36,46)42-14-8(3-38-43(35,45)41-13)40-20(12(14)32)30-5-24-10-16(30)27-21(22)28-18(10)34;22-8-1-2-24-18-11(8)27-6-29(18)20-13(31)15-9(39-20)3-37-44(35,36)42-16-10(4-38-43(33,34)41-15)40-21(14(16)32)30-7-28-12-17(23)25-5-26-19(12)30;22-8-1-2-24-18-11(8)27-6-29(18)20-13(31)15-9(37-20)3-35-42(34,44)40-16-10(4-36-41(33,43)39-15)38-21(14(16)32)30-7-28-12-17(23)25-5-26-19(12)30/h4-5,7-8,11-14,19-20,31-32H,2-3H2,1H3,(H,35,36)(H,37,38)(H,25,26,33)(H3,22,27,28,34);4-5,7-8,11-14,19-20,31-32H,2-3H2,1H3,(H,35,45)(H,36,46)(H,25,26,33)(H3,22,27,28,34);1-2,5-7,9-10,13-16,20-21,31-32H,3-4H2,(H2,22,24)(H,33,34)(H,35,36)(H2,23,25,26);1-2,5-7,9-10,13-16,20-21,31-32H,3-4H2,(H2,22,24)(H,33,43)(H,34,44)(H2,23,25,26)/t7-,8-,11?,12?,13+,14+,19-,20-;7-,8-,11?,12?,13+,14+,19-,20-,43?,44?;9-,10-,13?,14?,15+,16+,20-,21-;9-,10-,13?,14?,15+,16+,20-,21-,41?,42?/m1111/s1
• InChIKey: ZZQRSOIWOXGHAG-ZYMAQKKQSA-N
• XLogP: -5.42
• TPSA: 1169.34 Ų
• H-Bond Donors: 26
• H-Bond Acceptors: 76
• Rotatable Bonds: 8
• Heavy Atoms: 180
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2757.99
LogP ≤ 5	-5.42
H-Bond Donors ≤ 5	26
H-Bond Acceptors ≤ 10	76

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'thiol_2', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,18-trihydroxy-12-oxo-12-sulfanyl-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one?

The IUPAC name of (1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,18-trihydroxy-12-oxo-12-sulfanyl-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one (CID 162264085) is (1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,18-trihydroxy-12-oxo-12-sulfanyl-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one.

What is the SMILES notation for (1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,18-trihydroxy-12-oxo-12-sulfanyl-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one?

The canonical SMILES for (1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,18-trihydroxy-12-oxo-12-sulfanyl-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one is Cc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)(O)O[C@@H]4C(O)[C@H](n5cnc6c(=O)[nH]c(N)nc65)O[C@@H]4COP(=O)(O)O[C@@H]3C2O)c(=O)[nH]1.Cc1nc2c(ncn2[C@@H]2O[C@@H]3COP(O)(=S)O[C@@H]4C(O)[C@H](n5cnc6c(=O)[nH]c(N)nc65)O[C@@H]4COP(=O)(S)O[C@@H]3C2O)c(=O)[nH]1.Nc1ccnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@@H]3C(O)[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)O[C@@H]2C1O.Nc1ccnc2c1ncn2[C@@H]1O[C@@H]2COP(O)(=S)O[C@@H]3C(O)[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(O)(=S)O[C@@H]2C1O.

What is the InChIKey of (1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,18-trihydroxy-12-oxo-12-sulfanyl-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one?

The InChIKey is ZZQRSOIWOXGHAG-ZYMAQKKQSA-N. The full InChI is InChI=1S/C21H25N9O14P2.C21H25N9O12P2S2.C21H25N9O12P2.C21H25N9O10P2S2/c1-6-25-15-9(17(33)26-6)23-4-29(15)19-11(31)13-7(41-19)2-39-46(37,38)44-14-8(3-40-45(35,36)43-13)42-20(12(14)32)30-5-24-10-16(30)27-21(22)28-18(10)34;1-6-25-15-9(17(33)26-6)23-4-29(15)19-11(31)13-7(39-19)2-37-44(36,46)42-14-8(3-38-43(35,45)41-13)40-20(12(14)32)30-5-24-10-16(30)27-21(22)28-18(10)34;22-8-1-2-24-18-11(8)27-6-29(18)20-13(31)15-9(39-20)3-37-44(35,36)42-16-10(4-38-43(33,34)41-15)40-21(14(16)32)30-7-28-12-17(23)25-5-26-19(12)30;22-8-1-2-24-18-11(8)27-6-29(18)20-13(31)15-9(37-20)3-35-42(34,44)40-16-10(4-36-41(33,43)39-15)38-21(14(16)32)30-7-28-12-17(23)25-5-26-19(12)30/h4-5,7-8,11-14,19-20,31-32H,2-3H2,1H3,(H,35,36)(H,37,38)(H,25,26,33)(H3,22,27,28,34);4-5,7-8,11-14,19-20,31-32H,2-3H2,1H3,(H,35,45)(H,36,46)(H,25,26,33)(H3,22,27,28,34);1-2,5-7,9-10,13-16,20-21,31-32H,3-4H2,(H2,22,24)(H,33,34)(H,35,36)(H2,23,25,26);1-2,5-7,9-10,13-16,20-21,31-32H,3-4H2,(H2,22,24)(H,33,43)(H,34,44)(H2,23,25,26)/t7-,8-,11?,12?,13+,14+,19-,20-;7-,8-,11?,12?,13+,14+,19-,20-,43?,44?;9-,10-,13?,14?,15+,16+,20-,21-;9-,10-,13?,14?,15+,16+,20-,21-,41?,42?/m1111/s1.

What are the key properties of (1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,18-trihydroxy-12-oxo-12-sulfanyl-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one?

(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,18-trihydroxy-12-oxo-12-sulfanyl-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one has a molecular weight of 2757.99 g/mol, XLogP of -5.42, 8 rotatable bonds, 26 hydrogen bond donors, and 76 hydrogen bond acceptors.

Where does this data come from?

All data for (1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;(1R,6R,8R,10R,15R,17R)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one;9-[(1R,6R,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,18-trihydroxy-12-oxo-12-sulfanyl-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-2-methyl-1H-purin-6-one is sourced from PubChem (CID 162264085), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).